Indeed, GBM and BC‐derived brain lesions share the ability to recruit immunosuppressive myeloid cells expressing colony‐stimulating factor 1 receptor (CSF1R), ultimately generating a population of tumor‐associated macrophages (TAMs) that are dynamically altered during therapy. This evidence concerns the gene CSF1R and glioblastoma.